News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
5 Results
Section
Business (1)
Deals (1)
FDA (1)
News (3)
Policy (1)
Tag
Approvals (1)
C-suite (1)
FDA (1)
Mergers & acquisitions (1)
People (2)
Regulatory (1)
Date
Last 30 days (1)
Last 365 days (1)
2026 (1)
2023 (1)
2021 (1)
2019 (1)
2017 (1)
Location
Missouri (1)
United States (1)
5 Results for "custopharm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Par Health Names Dr. William Larkins as EVP and Chief Scientific Officer and President, Sterile Injectables
January 12, 2026
·
5 min read
Biotech Beach
Leucadia Pharmaceuticals Launches Calcitonin Salmon Injection
Leucadia Pharmaceuticals, a U.S. leader in generic injectables and the commercial arm of Custopharm, Inc., today announced the launch of its latest FDA-approved generic, Calcitonin Salmon Injection, USP, Synthetic.
May 20, 2021
·
3 min read
Deals
Custopharm Acquires Two ANDA Pharmaceutical Products From Perrigo
January 4, 2017
·
2 min read
Business
Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jeff Keyes as its new Chief Financial Officer, effective May 15, 2023.
May 2, 2023
·
7 min read
FDA
Leucadia Pharmaceuticals Launches Sodium Tetradecyl Sulfate Injection
Eagerly Anticipated FDA-Approved Generic to SOTRADECOL® Provides Safe and Effective Solution for Patients, Bypasses Risks Presented by Lower-Quality Compounded Alternatives
December 11, 2019
·
3 min read
